Efficacy and safety of a daytime anxiolytic containing technologically processed antibodies to the S100 protein. Overview of clinical studies

The review presents the results of clinical studies efficacy and safety Tenoten children’s in treatment anxiety, neurotic, stress-related somatoform disorders adjustment disorders. Technologically processed antibodies to S100 protein drugs change conformation protein, which is considered as a pathological link development anxiety states, well neurodegenerative diseases. well-studied daytime anxiolytic that combines favorable profile with high activity. comparable benzodiazepine drugs. has no inhibitory muscle relaxant effects, does not cause drug tolerance, addiction, "withdrawal" syndrome, interactions. for children been shown be effective children, including those somatic manifestations, attention deficit hyperactivity disorder, learning disabilities.